122 related articles for article (PubMed ID: 1125696)
1. Editorial: Breast cancer and the discriminant.
Br Med J; 1975 Apr; 2(5963):107-8. PubMed ID: 1125696
[No Abstract] [Full Text] [Related]
2. Probability of a woman with advanced breast cancer responding to adrenalectomy or hypophysectomy.
Sarfaty G; Tallis M
Lancet; 1970 Oct; 2(7675):685-7. PubMed ID: 4195930
[No Abstract] [Full Text] [Related]
3. Urinary steroids in the prediction of response to adrenalectomy or hypophysectomy. A second clinical trial.
Atkins H; Bulbrook RD; Falconer MA; Hayward JL; MacLean KC; Schurr PH
Lancet; 1968 Dec; 2(7581):1261-3. PubMed ID: 4177468
[No Abstract] [Full Text] [Related]
4. [Adrenalectomy as a therapeutic method of progressive mammary cancer].
Fujimori M; Izuo M; Higuchi T
Geka Chiryo; 1969 Oct; 21(4):445-55. PubMed ID: 4902446
[No Abstract] [Full Text] [Related]
5. Hormonal influences in breast cancer.
Forrest AP
Proc R Soc Med; 1971 May; 64(5):509-16. PubMed ID: 4252687
[No Abstract] [Full Text] [Related]
6. Prediction of response to adrenalectomy in the treatment of advanced breast cancer.
Masnyk IJ; Silverman DT; Hankey BF
J Natl Cancer Inst; 1978 Feb; 60(2):271-8. PubMed ID: 621745
[No Abstract] [Full Text] [Related]
7. [Steroids and breast cancer. Pharmacologic and therapeutic introduction].
Sala G; Perrotta P
Minerva Ginecol; 1970 Jul; 22(13):669-76. PubMed ID: 4921252
[No Abstract] [Full Text] [Related]
8. Urinary steroids and breast disease.
Gleave EN; Griffiths K; Cameron E; Wilson D; Campbell H; Forrest AP
Br J Surg; 1969 Aug; 56(8):627. PubMed ID: 5797766
[No Abstract] [Full Text] [Related]
9. Adrenal structure and function in advanced carcinoma of the breast. II. The relation of steroid excretion to adrenal morphology and the outcome of adrenalectomy, with description of a new discriminant function.
Wilson RE; Crocker DW; Fairgrieve J; Bartholomay AF; Emerson K; Moore FD
JAMA; 1967 Feb; 199(7):474-82. PubMed ID: 6071280
[No Abstract] [Full Text] [Related]
10. [The importance of studying steroid and hypophyseal hormone excretion in patients with dyshormonal tumors].
Sharoukhova KS
Vestn Akad Med Nauk SSSR; 1968; 23(3):63-8. PubMed ID: 5754742
[No Abstract] [Full Text] [Related]
11. [Clinical study on adrenal suppression and estrogens in recurrent breast cancer].
Nazaki R
Nihon Naibunpi Gakkai Zasshi; 1966 Oct; 42(7):788-800. PubMed ID: 6008079
[No Abstract] [Full Text] [Related]
12. Breast cancer--the Bullbrook discriminant.
Meyer KK
Rocky Mt Med J; 1968 Oct; 65(10):53-9. PubMed ID: 5681761
[No Abstract] [Full Text] [Related]
13. URINARY STEROID ESTIMATIONS IN THE PREDICTION OF RESPONSE TO ADRENALECTOMY OR HYPOPHYSECTOMY.
ATKINS H; BULBROOK RD; FALCONER MA; HAYWARD JL; MACLEAN KS; SCHURR PH
Lancet; 1964 Nov; 2(7370):1133-6. PubMed ID: 14213566
[No Abstract] [Full Text] [Related]
14. Urinary steroids in breast cancer.
Nature; 1969 Jan; 221(5177):218. PubMed ID: 5763075
[No Abstract] [Full Text] [Related]
15. [The mechanism of action of hydrocortisone administered by lumbar puncture in breast cancer].
Bordiushkov IuN; Mindlin SS; Verkhovtseva AI
Vopr Onkol; 1973; 19(9):19-23. PubMed ID: 4274750
[No Abstract] [Full Text] [Related]
16. Ten years' experience of sterioid assays in the management of breast cancer. A review.
Atkins H; Bulbrook RD; Falconer MA; Hayward JL; MacLean KS; Schurr PH
Lancet; 1968 Dec; 2(7581):1255-60. PubMed ID: 4177467
[No Abstract] [Full Text] [Related]
17. [Excretion of pituitary and steroid hormones in breast cancer following pituitary irradiation].
Izmaĭlova GE; Sharoukhova KS; Goncharova MG; Kuz'mina ZV; Murav'eva NI
Vestn Akad Med Nauk SSSR; 1972; 27(10):36-9. PubMed ID: 4641120
[No Abstract] [Full Text] [Related]
18. The urinary excretion of pregnanetriol and pregnenetriol in patients with breast cancer. A postulation on the meaning of Bulbrook's discriminant.
Gonçalves Sobrinho L; Faro L; Henriques EF; Botelho LS; Fontes De Sousa MF
Eur J Cancer (1965); 1976 Nov; 12(11):907-11. PubMed ID: 186269
[No Abstract] [Full Text] [Related]
19. [Ovaro-adrenalectomy and hypophysial radiosideration in metastatized cancer of the breast: considerations on the behavior of urinary steroids].
CATANIA VC; LADO P
Tumori; 1961; 47():32-51. PubMed ID: 13877311
[No Abstract] [Full Text] [Related]
20. Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.
BULBROOK RD; GREENWOOD FC; HAYWARD JL
Lancet; 1960 May; 1(7135):1154-7. PubMed ID: 13805841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
